Search results for "WEIGHT"

showing 10 items of 2980 documents

Salivary composition in obese vs normal-weight subjects: towards a role in postprandial lipid metabolism?

2015

In the pathophysiological context of obesity, oral exposure to dietary fat can modulate lipid digestion and absorption but underlying in-mouth mechanisms have not been clearly identified. Therefore we tested the hypothesis that salivary components related to dietary fat sensitivity would differ according to BMI and postprandial lipid metabolism in young men. Saliva was collected from 9 normal-weight (BMI=22.3±0.5 kg/m2) and 9 non-morbid obese (BMI=31.7±0.3 kg/m2) men before a 8 h-postprandial metabolic exploration test involving the consumption of a 40 g fat-meal, in which obese subjects revealed a delayed postprandial lipid metabolism. Nine salivary characteristics (flow, protein content, …

AdultBlood GlucoseMaleSalivamedicine.medical_specialtyproteolysis030309 nutrition & dieteticsEndocrinology Diabetes and Metabolism[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionMedicine (miscellaneous)Context (language use)salivary compositionBody Mass Index03 medical and health sciencesThinnessInternal medicinelipid metabolismmedicineLipolysisHumansObesitySalivaMeals030304 developmental biology0303 health sciencesNutrition and Dieteticsobesebusiness.industryLipid metabolism[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismPostprandial PeriodDietary Fats3. Good healthPostprandialEndocrinologylipolysismedicine.symptombusinessEnergy MetabolismWeight gainBody mass indexLipid digestion[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Ensayo no aleatorizado de un programa de fisioterapia continuo frente a interválico para pacientes con sobrepeso y síndrome coronario agudo

2020

Resumen: Presentamos un ensayo no aleatorizado de un programa de fisioterapia continuo frente a interválico para pacientes con sobrepeso y síndrome coronario agudo. Objetivo: Detectar diferencias entre un programa de fisioterapia (PF) continuo (CONT) y uno interválico (INT) en pacientes con sobrepeso y síndrome coronario agudo, respecto a parámetros antropométricos, analíticos, frecuencia cardiaca de reposo, adherencia a la intervención, desgaste, seguridad y tolerancia. Diseño: Estudio multicéntrico cuasiexperimental con diseño pre-post, no aleatorizado con muestreo por conveniencia con 2 brazos de tratamiento. Emplazamiento: Centros de prevención cardiaca comunitaria (Departamentos de Sal…

AdultBlood GlucoseMaleTime FactorsNon-Randomized Controlled Trials as TopicWarm-Up Exercise030204 cardiovascular system & hematologyBody Mass Index03 medical and health sciences0302 clinical medicineHeart RateHumansSíndrome coronario agudo030212 general & internal medicinePhysiotherapyFisioterapiaTriglyceridesAgedlcsh:R5-920PreventionGeneral MedicineMiddle AgedOverweightOriginalesLipidsExercise TherapyPrevenciónCool-Down ExerciseSobrepesoPhysical EnduranceFemaleAcute coronary syndromeWaist Circumferencelcsh:Medicine (General)Family PracticeAtención Primaria
researchProduct

Role of skeletal muscle-fibre type in regulation of glucose metabolism in middle-aged subjects with impaired glucose tolerance during a long-term exe…

2005

Aim: The aim of this study was to investigate the role of skeletal muscle fibre type in the regulation of glucose metabolism in middle-aged obese subjects with impaired glucose tolerance (IGT) during a 2-year exercise anddietary intervention. Methods: Muscle biopsies (musculus vastus lateralis) were taken from 22 subjects belonging to the intervention group of the Finnish Diabetes Prevention Study [1]. According to their myosin heavy chain (MHC) profile at the baseline, the subjects were divided into two groups: IGT s l o w (n = 10) with a high proportion of MHC I isoforms and IGT f a s t (n = 12) with a high proportion of MHC II isoforms in the vastus lateralis muscle. The intervention con…

AdultBlood GlucoseMaleVascular Endothelial Growth Factor Amedicine.medical_specialtyDiet Reducingendocrine system diseasesVastus lateralis muscleEndocrinology Diabetes and MetabolismMuscle Fibers SkeletalCarbohydrate metabolismImpaired glucose toleranceGlycogen Synthase Kinase 3EndocrinologyInsulin resistanceDiabetes mellitusInternal medicineGlucose IntoleranceWeight LossInternal MedicinemedicineHumansAerobic exerciseObesityMuscle SkeletalGlycogen synthaseExerciseAgedMyosin Heavy Chainsbiologybusiness.industrynutritional and metabolic diseasesSkeletal muscleMiddle Agedmedicine.diseaseCombined Modality Therapymedicine.anatomical_structureEndocrinologybiology.proteinFemalebusinesshormones hormone substitutes and hormone antagonistsFollow-Up StudiesDiabetes, Obesity and Metabolism
researchProduct

Effects of hypocaloric diets with different glycemic indexes on endothelial function and glycemic variability in overweight and in obese adult patien…

2013

Background & aims: The role of glycemic index of the diet in glucose control and cardiovascular prevention is still not clear. The aim of this study was to determine the effects of hypocaloric diets with different glycemic indexes and glycemic loads on endothelial function and glycemic variability in nondiabetic participants at increased cardiovascular risk. Methods: Forty nondiabetic obese participants were randomly assigned to a three-month treatment with either a low glycemic index (LGI; n ¼ 19) or high glycemic index (HGI; n ¼ 21) hypocaloric diet with similar macronutrient and fiber content. Endothelial function was measured as flow-mediated dilatation (FMD) of the brachial artery befo…

AdultBlood GlucoseMalemedicine.medical_specialtyAdolescentBrachial ArteryOverweightCritical Care and Intensive Care MedicineGastroenterologyBody Mass IndexYoung AdultInsulin resistanceRisk FactorsWeight lossInternal medicineWeight LossGlycemic loadDiabetes MellitusmedicineBody Fat DistributionHumansInsulinendothelial function glycemic variability diet glycemic index glycemic load cardiovascular riskEndotheliumObesitySettore MED/49 - Scienze Tecniche Dietetiche ApplicateCaloric RestrictionGlycemicNutrition and Dieteticsbusiness.industryMiddle AgedOverweightmedicine.diseaseGlycemic indexEndocrinologyCardiovascular DiseasesGlycemic IndexBody CompositionFemaleInsulin Resistancemedicine.symptomEnergy IntakebusinessBody mass indexDietingClinical Nutrition
researchProduct

Insulin sensitivity and secretion and adipokine profile in patients with Cushing’s disease treated with pasireotide

2018

Purpose: To evaluate the effect of pasireotide on β-cell and adipose function in patients with Cushing’s disease (CD). Methods: Clinical and hormonal parameters, insulin secretion evaluated by HOMA-β and by the area under the curve (AUC2h) of C-peptide during a mixed meal tolerance test and insulin sensitivity, evaluated by the euglycaemic hyperinsulinaemic clamp, were evaluated in 12 patients with active CD, before and after 6 and 12 months of pasireotide. In addition, a panel of adipokines including leptin (Ob), leptin/leptin receptor ratio (Ob/Ob-R ratio), adiponectin, resistin, visfatin, adipocyte fatty acid binding protein (AFABP) and non-esterified fatty acids (NEFAs) was evaluated at…

AdultBlood GlucoseMalemedicine.medical_specialtyDiabetes mellituInjections SubcutaneousEndocrinology Diabetes and MetabolismAdipose tissueAdipokine030209 endocrinology & metabolism030204 cardiovascular system & hematologySettore MED/13 - EndocrinologiaCohort StudiesYoung Adult03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyAdipokinesInternal medicineDiabetes mellitusAdipokinemedicineHumansInsulinPituitary ACTH HypersecretionLeptin receptorAdiponectinbusiness.industryLeptinBody WeightMiddle AgedCushing’s diseasemedicine.diseaseInsulin sensitivityHormonesPasireotidePasireotideTreatment OutcomeEndocrinologychemistryFemaleResistinInsulin ResistanceSomatostatinbusiness
researchProduct

Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial

2016

OBJECTIVE To compare the efficacy and safety of liraglutide versus lixisenatide as add-on to metformin in patients with type 2 diabetes not achieving adequate glycemic control on metformin alone. RESEARCH DESIGN AND METHODS In this 26-week, randomized, parallel-group, open-label trial, 404 patients were randomized 1:1 to liraglutide 1.8 mg or lixisenatide 20 µg as add-on to metformin. Liraglutide was administered once daily at any time of the day. Lixisenatide was administered once daily within 1 h prior to the morning or evening meal. RESULTS At week 26, liraglutide reduced HbA1c (primary end point) more than lixisenatide (estimated treatment difference −0.62% [95% CI −0.8; −0.4]; P &…

AdultBlood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismType 2 diabetes030204 cardiovascular system & hematologyHypoglycemiaDrug Administration Schedulelaw.inventionYoung Adult03 medical and health sciencesLixisenatidechemistry.chemical_compound0302 clinical medicineRandomized controlled triallawInternal medicineInternal MedicinemedicineClinical endpointHumansHypoglycemic AgentsAgedGlycemicAged 80 and overGlycated HemoglobinAdvanced and Specialized NursingLiraglutidebusiness.industryBody WeightLiraglutideMiddle AgedPostprandial Periodmedicine.diseaseHypoglycemiaMetforminMetforminTreatment OutcomeEndocrinologyDiabetes Mellitus Type 2chemistryDrug Therapy CombinationFemalePeptidesbusinessmedicine.drugDiabetes Care
researchProduct

Metabolic changes induced by combined prolonged exercise and low-calorie intake in man

1984

Thirteen middle-aged women and 10 men walked 344 km during 7 days. The daily walking distances were 57, 53, 67, 53, 41, 36, and 37 km at an average speed of 3.5 km X h-1. During the hike the subjects drank water, mineral drinks, and juices ad libitum. Except for some natural products, no food intake was allowed. During the hike the body weight and serum protein concentration of the subjects decreased by about 7%, on average. Serum triglyceride and total cholesterol decreased drastically, about 30-40% during the hike, but HDL-cholesterol showed a tendency to increase, giving a 40% increment in HDL/total cholesterol ratio. Serum free fatty acids rose 1.5-2 times above the starting level. Seru…

AdultBlood GlucoseMalemedicine.medical_specialtyEveningEpinephrinePhysiologymedicine.medical_treatmentPhysical ExertionPhysical exerciseFatty Acids NonesterifiedNorepinephrinechemistry.chemical_compoundPhysiology (medical)Internal medicinemedicineHumansInsulinTestosteroneOrthopedics and Sports MedicineAspartate AminotransferasesTriglyceridesTestosteroneTriglycerideCholesterolbusiness.industryInsulinBody WeightCholesterol HDLPublic Health Environmental and Occupational HealthFastinggamma-GlutamyltransferaseGeneral MedicineMetabolismMiddle AgedCholesterolEndocrinologychemistryFemaleEnergy IntakeEnergy MetabolismbusinessHormoneEuropean Journal of Applied Physiology and Occupational Physiology
researchProduct

Long term successful weight loss with a combination biphasic ketogenic mediterranean diet and mediterranean diet maintenance protocol.

2013

Weight loss protocols can only be considered successful if they deliver consistent results over the long term—a goal which is often elusive, so much so that the term “yo-yo” is used to describe the perennial weight loss/weight regain battle common in obesity. We hypothesized that a ketogenic Mediterranean diet with phytoextracts (KEMEPHY) combined with the acknowledged health benefits of traditional Mediterranean nutrition may favor long term weight loss. We analysed 89 male and female obese subjects, aged between 25 and 65 years who were overall healthy apart from being overweight. The subjects followed a staged diet protocol over a period of 12 months: 20 day of KEMEPHY; 20 days low carb-…

AdultBlood GlucoseMalemedicine.medical_specialtyMediterranean dietmedicine.medical_treatmentPhysiologylcsh:TX341-641BiologyOverweightHealth benefitsDiet MediterraneanArticleketogenic diet exercisechemistry.chemical_compoundWeight lossphytoextractsInternal medicineMediterranean dietWeight LossmedicineDietary CarbohydratesHumansObesityketogenic diet; Mediterranean diet; long term; phytoextractsTriglyceridesAgedRetrospective StudiesCreatinineNutrition and DieteticsCholesterolPlant ExtractsMiddle Agedmedicine.diseaseObesityDietary FatsEndocrinologyCholesterolchemistryketogenic dietFemalelong termDietary Proteinsmedicine.symptomDiet KetogenicEnergy Intakelcsh:Nutrition. Foods and food supplyFood ScienceKetogenic diet
researchProduct

A low reported energy intake is associated with metabolic syndrome.

2009

Background and aims: Metabolic syndrome (MS) may be associated with the presence of an energy sparing metabolism that predisposes to the excess accumulation of body fat. This study examined the relationship between reported energy intake and obesity in individuals with and without MS. Methods and results: Ninety consecutive non-diabetic obese subjects were divided into two groups based on the presence (MS+: n= 50) or absence (MS-: n= 40) of metabolic syndrome. The study design was cross-sectional. The three-day food record method was used to assess the subjects' usual energy intake and the Diet Readiness Test (DRT) was also administered. Compared to the MS- group, the MS+ group had a signif…

AdultBlood GlucoseMalemedicine.medical_specialtyMetabolic syndrome energy intake obesityEndocrinology Diabetes and MetabolismBlood PressureBody weightFat massBody Mass IndexEndocrinologyHeart RateInternal medicinemedicineHumansInsulinObesityMetabolic SyndromeInsulin bloodbusiness.industryBody Weightmedicine.diseaseObesityFood recordEndocrinologyBody CompositionLinear ModelsObese subjectsFemaleBasal MetabolismMetabolic syndromebusinessEnergy IntakeBody mass index
researchProduct

Body weight variation and control of cardiovascular risk factors in essential hypertension.

2009

The objective was to assess the impact of weight changes on blood pressure (BP), lipids and glucose goals in a cohort of hypertensive subjects.Prospective follow-up.Hypertension clinic.326 hypertensive non-diabetic subjects, 46% with metabolic syndrome (MS).Usual care treatment, which included diet, physical exercise and drugs prescribed when indicated. All patients were observed for up to 1 year.BP and low-density lipoprotein-cholesterol (LDL-C) goal were those in ESH/ESC and ATP III recommendations, respectively. The glucose goal was to delay progression to type 2 diabetes mellitus, or to achieve blood glucose100 mg/dl for non-diabetics. According to body weight changes, patients were cat…

AdultBlood GlucoseMalemedicine.medical_specialtyPhysical exerciseBlood PressureEssential hypertensionWeight GainCohort StudiesRisk FactorsInternal medicineWeight LossInternal MedicinemedicineHumansProspective StudiesProspective cohort studyMetabolic Syndromebusiness.industryType 2 Diabetes MellitusGeneral MedicineMiddle Agedmedicine.diseaseLipidsDietExercise TherapyBlood pressureEndocrinologyCardiovascular DiseasesCohortHypertensionFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessCohort studyFollow-Up StudiesBlood pressure
researchProduct